NCT05586035

Brief Summary

Surgical resection is the primary treatment for pulmonary tumors. Surgeons has been frequently concerned about effectiveness, safety, and minimal invasive techniques. However, persistent cough, one of the most common complications of lung surgery, has received insufficient attention. This study set out to investigate the risk factors and treatment related to persistent cough after pulmonary resection.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 2, 2021

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

October 16, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 19, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2023

Completed
Last Updated

October 19, 2022

Status Verified

October 1, 2022

Enrollment Period

1.3 years

First QC Date

October 16, 2022

Last Update Submit

October 16, 2022

Conditions

Persistent CoughPneumonectomyLung Neoplasms

Outcome Measures

Primary Outcomes (1)

  • Occurence rate of persistent cough after pulmonary resection

    Occurence rate of persistent cough after pulmonary resection

    Persistent cough after pulmonary resection is monitored from the time of surgery, up to 12 months.

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients underwent pulmonary resection in Guangdong Provincial People's Hospital and Shenzhen People's Hospital were eligible for this study.

You may qualify if:

  • Patients who received pulmonary resection;
  • to 85-year-old;
  • Pathologically diagnosed as NSCLC or benign tumor.

You may not qualify if:

  • Multiple malignancy in other parts of body;
  • Refuse to participate in this study;
  • Other situations evaluated by investigators not meet the enrollment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, 510080, China

RECRUITING

MeSH Terms

Conditions

Chronic CoughLung Neoplasms

Condition Hierarchy (Ancestors)

CoughRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung Diseases

Central Study Contacts

Guibin Qiao, M.D., Ph.D.

CONTACT

13602749153guibinqiao@126.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2022

First Posted

October 19, 2022

Study Start

September 2, 2021

Primary Completion

December 30, 2022

Study Completion

August 30, 2023

Last Updated

October 19, 2022

Record last verified: 2022-10

Locations

CN(1)